Amedisys Reports Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St set for higher open after Micron revives AI optimism, upbeat economic data
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Amedisys (AMED) Tops Q3 EPS by 11c
October 29, 2014 7:03 AM EDTAmedisys (NASDAQ: AMED) reported Q3 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $300.3 million versus the consensus estimate of $299.26 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More